We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.56T
1-Year Est. Return 27.86%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
+0.39%
1 Year Est. Return
+27.86%
3 Year Est. Return
+90.49%
5 Year Est. Return
+115.47%
10 Year Est. Return
+468.9%
AUM
$424B
AUM Growth
-$14.8B
Cap. Flow
+$4.42B
Cap. Flow %
1.04%
Top 10 Hldgs %
16.82%
Holding
4,397
New
356
Increased
1,656
Reduced
1,613
Closed
411

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$1.06B
2
MON
Monsanto Co
MON
+$890M
3
CVS icon
CVS Health
CVS
+$779M
4
SLB icon
SLB Ltd
SLB
+$600M
5
CVX icon
Chevron
CVX
+$573M

Sector Composition

Rank Sector Weight
1 Financials 14.33%
2 Healthcare 12.01%
3 Technology 10.9%
4 Consumer Discretionary 8.31%
5 Industrials 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARO
3676
CALL
DELISTED
Aeropostale Inc
ARO
$97K ﹤0.01%
+60,000
New +$158K
AMCC
3677
DELISTED
Applied Micro Circuits Corporation New
AMCC
$97K ﹤0.01%
+14,450
New +$88.3K
ARRY
3678
DELISTED
Array Biopharma Inc
ARRY
$96K ﹤0.01%
13,300
-149,051
-92% -$1.1M
PBT
3679
Permian Basin Royalty Trust
PBT
$1.36B
$89K ﹤0.01%
11,021
-10,000
-48% -$86.9K
TGA
3680
DELISTED
Transglobe Energy Corp
TGA
$89K ﹤0.01%
22,408
+6,170
+38% +$25.5K
KODK.WS
3681
DELISTED
Eastman Kodak Company
KODK.WS
$89K ﹤0.01%
21,916
MOBL
3682
DELISTED
MobileIron, Inc.
MOBL
$89K ﹤0.01%
15,009
-98,932
-87% -$688K
TAC icon
3683
TransAlta
TAC
$3.93B
$84K ﹤0.01%
10,895
-33,423
-75% -$301K
PWE
3684
DELISTED
Penn West Energy Petroleum Ltd
PWE
$84K ﹤0.01%
48,791
-954,492
-95% -$1.97M
EXC icon
3685
PUT
Exelon
EXC
$48.1B
$82K ﹤0.01%
3,645
-3,645
-50% -$87.3K
LIOX
3686
DELISTED
Lionbridge Technologies
LIOX
$79K ﹤0.01%
+12,860
New +$75.1K
RPRX
3687
DELISTED
Repros Therapeutics Inc.
RPRX
$79K ﹤0.01%
+11,068
New +$86.2K
JCP
3688
CALL
DELISTED
J.C. Penney Company, Inc.
JCP
$78K ﹤0.01%
9,200
-177,100
-95% -$1.53M
NOG icon
3689
Northern Oil and Gas
NOG
$2.29B
$77K ﹤0.01%
1,139
GAZ
3690
DELISTED
iPath Bloomberg Natural Gas Subindex Total Return ETN due October 22, 2037
GAZ
$76K ﹤0.01%
59,858
GSK icon
3691
CALL
GSK
GSK
$107B
$75K ﹤0.01%
1,440
-4,160
-74% -$234K
DXM
3692
DELISTED
DEX MEDIA INC NEW COM STK (DE)
DXM
$75K ﹤0.01%
102,822
-215,908
-68% -$424K
MO icon
3693
CALL
Altria Group
MO
$125B
$73K ﹤0.01%
1,500
-1,000
-40% -$50.7K
MCGC
3694
DELISTED
MCG CAP CORP
MCGC
$68K ﹤0.01%
+15,148
New +$67.8K
CBAY
3695
DELISTED
Cymabay Therapeutics
CBAY
$67K ﹤0.01%
+25,000
New +$103K
REFR icon
3696
Research Frontiers
REFR
$13.6M
$64K ﹤0.01%
+12,077
New +$71.1K
KODK.WS.A
3697
DELISTED
Eastman Kodak Company
KODK.WS.A
$63K ﹤0.01%
16,814
COVS
3698
DELISTED
Covisint Corporation
COVS
$62K ﹤0.01%
18,883
-347,284
-95% -$823K
GCVRZ
3699
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$61K ﹤0.01%
87,112
+37,311
+75% +$25.8K
ADYX
3700
DELISTED
Adynxx Inc
ADYX
$60K ﹤0.01%
+189
New +$55.9K

Similar funds

JP Morgan Chase's Q2 2015 Portfolio in Review

As of Q2 2015, JP Morgan Chase held 4,397 positions worth $424B, down 3.4% from $439B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

JP Morgan Chase's Q2 2015 filing shows 356 new, 1,656 increased, 1,613 reduced and 411 closed positions. Its largest new stake was Fitbit, Inc. Class A common stock: 1,923,189 shares worth $73.5M. The largest sale was Johnson & Johnson, an estimated $1.06B.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.

  • JP Morgan Chase's largest Q2 2015 buy was Fitbit, Inc. Class A common stock: 1,923,189 shares worth $73.5M.
  • JP Morgan Chase added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $2.07B increase.
  • JP Morgan Chase's biggest Q2 2015 reduction was Johnson & Johnson, cutting an estimated $1.06B.
  • JP Morgan Chase fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $342M.
  • JP Morgan Chase's ten largest holdings make up 17% of its $424B portfolio in Q2 2015.
  • JP Morgan Chase opened 356 new positions and closed 411 in Q2 2015.
  • JP Morgan Chase's portfolio value fell 3.4% quarter-over-quarter to $424B.

Based on JP Morgan Chase's 13F filing for Q2 2015, filed 14 Aug 2015.